Behind the Green Door: Drug Testing Medical Cannabis and CBD in Chronic Pain Patients

The recent changes in many state laws around the use of cannabis and cannabis- containing products has markedly changed the landscape around drug testing. False positives—and even false negatives—can lead to a lack of confidence in the entire drug testing process. In this presentation, there we will discuss the impact of cannabidiol-containing products (CBD) on the interpretation of both presumptive and definitive testing. Particular emphasis will be applied to test interpretation of positive results in the context of “allowable or prescribed” confounding drugs.

Learning Objectives

  • Discuss drug testing methods in the context of state vs federal law
  • Examine the Hemp Farming Act 2018, especially as it applies to CBD
  • Explain how the “false positive drug test” can happen
  • List what your patient can do about the “false positive drug test”
  • Review your options in the context of marijuana use and prescription opioids

Additional Information

AttachmentSize
PDF icon Slides and Disclosures674.38 KB
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
06/01/2021
Course expires: 
06/01/2022
Part of: 
Cannabinoids Track
Rating: 
0

image

Doug L. Gourlay, MD, MSc, FRCPC, FASAM

Anesthesiologist
Private Practice
Hamilton, Ontario, Canada

Available Credit

  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.